Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
* Sikiric P, Seiwerth S, Rucman R, Kolenc D, Rak D, Drmic D, et al
320 (5), G759G767
Because they're patented properties, it's unclear how these branded forms can withstand the digestive environment, but both have demonstrated their potential to do so in clinical studies
Back to Journals Biologics: Targets and Therapy Volume 19 Effects of Dulaglutide in Doxorubicin Induced Renal Toxicity in Rats Authors Hama Said HJ , Ahmed ZA Received 18 February 2025 Accepted for publication 18 June 2025 Published 3 July 2025 Volume 2025:19 Pages 399412 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Shein-Chung Chow Hogr Jasim Hama Said, Zheen Aorahman Ahmed Department of Pharmacology and Toxicology, College of Pharmacy, University of Sulaimani, Sulaimani, Kurdistan Region, Iraq Correspondence: Zheen Aorahman Ahmed, Email [email protected] Objective: The present study was designed to determine the anti-inflammatory and antioxidant effects of dulaglutide (DUL) on doxorubicin (DOX) -induced acute kidney injury (AKI)
10.1093/jn/130.5.1437S 248
RESULTS: BPC-157 demonstrated potential benefits in tendon and muscle repair, but these findings are largely unvalidated in human trials
US$ 22.22
US$ 28.48
US$ 22.76
US$ 29.65
